Viral safety in homoeopathic medicinal products.

(Extraído de PubMed.com)

Pharmeur Bio Sci Notes. 2011 Jun;2011(1):55-65.

Schultz N, Franck-Karl G, Schilk J, Rose N.

Source

Homöopathisches Laboratorium A. Pflüger GmbH & Co. KG, Röntgenstrasse 4, Rheda-Wiedenbrück, Germany. n.schultz@pflueger.de

Abstract

To guarantee the safety of medicinal products as regards infectious agents, numerous national guidelines and recommendations have in recent years been included in the pharmacopoeia general monographs and have influenced the content of the substance monographs. Although the stipulations of the European Pharmacopoeia set out objectives, there is still a certain scope in how the requirements are implemented. This is reflected in the very different responses in Europe to the problems of safety from infection. Different traditions in the use of homoeopathic and anthroposophic therapy and varying levels of expertise among the regulatory authorities within the European Union have resulted in varying standard of assessment. The aim of this publication is to present a standard form of assessment for medicinal products in these therapeutic systems. Demonstrated hereunder is an approach that can be adopted to ensure that the high safety standard required is met for homoeopathic and anthroposophic medicinal products.